• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子 MRI 的癌症免疫治疗反应监测。

Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.

机构信息

Department of Biomedical Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.

Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.

出版信息

Int J Mol Sci. 2023 Feb 5;24(4):3151. doi: 10.3390/ijms24043151.

DOI:10.3390/ijms24043151
PMID:36834563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9959624/
Abstract

Immunotherapy constitutes a paradigm shift in cancer treatment. Its FDA approval for several indications has yielded improved prognosis for cases where traditional therapy has shown limited efficiency. However, many patients still fail to benefit from this treatment modality, and the exact mechanisms responsible for tumor response are unknown. Noninvasive treatment monitoring is crucial for longitudinal tumor characterization and the early detection of non-responders. While various medical imaging techniques can provide a morphological picture of the lesion and its surrounding tissue, a molecular-oriented imaging approach holds the key to unraveling biological effects that occur much earlier in the immunotherapy timeline. Magnetic resonance imaging (MRI) is a highly versatile imaging modality, where the image contrast can be tailored to emphasize a particular biophysical property of interest using advanced engineering of the imaging pipeline. In this review, recent advances in molecular-MRI based cancer immunotherapy monitoring are described. Next, the presentation of the underlying physics, computational, and biological features are complemented by a critical analysis of the results obtained in preclinical and clinical studies. Finally, emerging artificial intelligence (AI)-based strategies to further distill, quantify, and interpret the image-based molecular MRI information are discussed in terms of perspectives for the future.

摘要

免疫疗法是癌症治疗的一种范式转变。其在美国食品和药物管理局 (FDA) 的多项批准,为传统疗法疗效有限的病例带来了更好的预后。然而,许多患者仍然无法从这种治疗模式中获益,并且肿瘤反应的确切机制尚不清楚。非侵入性的治疗监测对于肿瘤的纵向特征描述和对无应答者的早期检测至关重要。虽然各种医学成像技术可以提供病变及其周围组织的形态图像,但分子导向的成像方法是揭示免疫治疗时间线上更早发生的生物学效应的关键。磁共振成像 (MRI) 是一种高度通用的成像方式,通过对成像管道进行先进的工程设计,可以针对特定的感兴趣的生物物理特性来调整图像对比度。在这篇综述中,描述了基于分子 MRI 的癌症免疫治疗监测的最新进展。接下来,通过对临床前和临床研究中获得的结果进行批判性分析,对基础物理学、计算和生物学特征进行了介绍。最后,根据未来的展望,讨论了基于人工智能 (AI) 的新兴策略,以进一步提取、量化和解释基于图像的分子 MRI 信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/31fc0c8e2fb6/ijms-24-03151-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/398ce3231815/ijms-24-03151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/0aadb8e14524/ijms-24-03151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/260f61ebec8e/ijms-24-03151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/96385d684e00/ijms-24-03151-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/88a7bfca0525/ijms-24-03151-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/0d627e49890b/ijms-24-03151-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/31fc0c8e2fb6/ijms-24-03151-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/398ce3231815/ijms-24-03151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/0aadb8e14524/ijms-24-03151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/260f61ebec8e/ijms-24-03151-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/96385d684e00/ijms-24-03151-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/88a7bfca0525/ijms-24-03151-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/0d627e49890b/ijms-24-03151-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/600b/9959624/31fc0c8e2fb6/ijms-24-03151-g007.jpg

相似文献

1
Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response.基于分子 MRI 的癌症免疫治疗反应监测。
Int J Mol Sci. 2023 Feb 5;24(4):3151. doi: 10.3390/ijms24043151.
2
Current Status and Future Perspectives of Artificial Intelligence in Magnetic Resonance Breast Imaging.人工智能在磁共振乳腺成像中的现状与未来展望。
Contrast Media Mol Imaging. 2020 Aug 28;2020:6805710. doi: 10.1155/2020/6805710. eCollection 2020.
3
An Update on MR Spectroscopy in Cancer Management: Advances in Instrumentation, Acquisition, and Analysis.癌症管理中磁共振波谱的最新进展:仪器、采集和分析的进展。
Radiol Imaging Cancer. 2024 May;6(3):e230101. doi: 10.1148/rycan.230101.
4
Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.使用氯尼达明进行肿瘤选择性酸化后成像化学交换饱和转移(CEST)效应。
NMR Biomed. 2015 May;28(5):566-75. doi: 10.1002/nbm.3287. Epub 2015 Mar 23.
5
Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T.7T 下化学交换饱和转移成像在脑胶质瘤患者根治性放化疗早期疗效评估中的应用
J Magn Reson Imaging. 2019 Oct;50(4):1268-1277. doi: 10.1002/jmri.26702. Epub 2019 Mar 12.
6
Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.多参数化学交换饱和转移 MRI 检测免疫治疗后乳腺癌的代谢变化。
J Transl Med. 2023 Aug 28;21(1):577. doi: 10.1186/s12967-023-04451-6.
7
Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection.非热量甜味剂为癌症检测提供磁共振成像造影剂。
J Transl Med. 2017 May 30;15(1):119. doi: 10.1186/s12967-017-1221-9.
8
A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI.一种利用化学交换饱和转移(CEST)磁共振成像进行精确pH值映射的方法。
Contrast Media Mol Imaging. 2016 May;11(3):195-202. doi: 10.1002/cmmi.1680. Epub 2015 Dec 21.
9
Breast PET/MRI Hybrid Imaging and Targeted Tracers.乳腺 PET/MRI 融合成像与靶向示踪剂。
J Magn Reson Imaging. 2023 Feb;57(2):370-386. doi: 10.1002/jmri.28431. Epub 2022 Sep 27.
10
pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI.使用胺化学交换饱和转移磁共振成像对胶质瘤进行pH加权分子成像。
Neuro Oncol. 2015 Nov;17(11):1514-24. doi: 10.1093/neuonc/nov106. Epub 2015 Jun 24.

引用本文的文献

1
The role of radiotheranostics in personalized treatment for breast cancer.放射治疗诊断学在乳腺癌个性化治疗中的作用。
Med Oncol. 2025 Jul 11;42(8):322. doi: 10.1007/s12032-025-02825-y.
2
Current Trends and Advances in Nanoplatforms-Based Imaging for Cancer Diagnosis.基于纳米平台的癌症诊断成像的当前趋势与进展
Indian J Microbiol. 2025 Mar;65(1):137-176. doi: 10.1007/s12088-024-01373-9. Epub 2024 Aug 9.
3
Quantitative molecular imaging using deep magnetic resonance fingerprinting.使用深度磁共振指纹识别的定量分子成像。

本文引用的文献

1
Conventional and Advanced Imaging Techniques in Post-treatment Glioma Imaging.治疗后胶质瘤成像中的传统与先进成像技术
Front Radiol. 2022 Jun 28;2:883293. doi: 10.3389/fradi.2022.883293. eCollection 2022.
2
Adaptive model-based Magnetic Resonance.基于自适应模型的磁共振。
Magn Reson Med. 2023 Sep;90(3):839-851. doi: 10.1002/mrm.29688. Epub 2023 May 8.
3
Accelerated and quantitative three-dimensional molecular MRI using a generative adversarial network.使用生成对抗网络进行加速和定量的三维分子 MRI。
Nat Protoc. 2025 Apr 1. doi: 10.1038/s41596-025-01152-w.
4
Recent advances in non-invasive tracking of cell-based cancer immunotherapies.基于细胞的癌症免疫疗法非侵入性追踪的最新进展。
Biomater Sci. 2025 Apr 8;13(8):1939-1959. doi: 10.1039/d4bm01677g.
5
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment.分子成像在靶向肿瘤免疫微环境中的现状与未来前景
Front Immunol. 2025 Jan 22;16:1518555. doi: 10.3389/fimmu.2025.1518555. eCollection 2025.
6
A comprehensive neuroimaging review of the primary and metastatic brain tumors treated with immunotherapy: current status, and the application of advanced imaging approaches and artificial intelligence.免疫疗法治疗原发性和转移性脑肿瘤的综合神经影像学综述:现状、先进成像方法及人工智能的应用
Front Immunol. 2024 Nov 28;15:1496627. doi: 10.3389/fimmu.2024.1496627. eCollection 2024.
7
Essential magnetosome proteins MamI and MamL from magnetotactic bacteria interact in mammalian cells.来自趋磁细菌的必需磁小体蛋白 MamI 和 MamL 在哺乳动物细胞中相互作用。
Sci Rep. 2024 Nov 1;14(1):26292. doi: 10.1038/s41598-024-77591-4.
8
CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials.嵌合抗原受体 T 细胞疗法治疗小儿中枢神经系统肿瘤:文献复习和当前北美试验。
Cancer Metastasis Rev. 2024 Dec;43(4):1205-1216. doi: 10.1007/s10555-024-10208-4. Epub 2024 Sep 9.
9
Deep learning for accelerated and robust MRI reconstruction.深度学习在加速和稳健 MRI 重建中的应用。
MAGMA. 2024 Jul;37(3):335-368. doi: 10.1007/s10334-024-01173-8. Epub 2024 Jul 23.
10
Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.基于磁共振成像的方法检测在结直肠癌模型中联合 VEGFR-2 和 PD-1 阻断治疗的疗效。
J Transl Med. 2024 Feb 23;22(1):198. doi: 10.1186/s12967-024-04975-5.
Magn Reson Med. 2023 May;89(5):1901-1914. doi: 10.1002/mrm.29574. Epub 2022 Dec 31.
4
Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages.多光谱氟-19磁共振成像能够对肿瘤相关巨噬细胞进行纵向和非侵入性监测。
Sci Transl Med. 2022 Oct 19;14(667):eabo2952. doi: 10.1126/scitranslmed.abo2952.
5
In Vivo MRI-CEST Tumor pH Imaging Detects Resistance to Proton Pump Inhibitors in Human Prostate Cancer Murine Models.体内磁共振成像-化学交换饱和转移肿瘤pH成像检测人前列腺癌小鼠模型对质子泵抑制剂的耐药性
Cancers (Basel). 2022 Oct 7;14(19):4916. doi: 10.3390/cancers14194916.
6
CEST MR fingerprinting (CEST-MRF) for brain tumor quantification using EPI readout and deep learning reconstruction.基于 EPI 读取和深度学习重建的脑肿瘤定量 CEST MR 指纹技术(CEST-MRF)
Magn Reson Med. 2023 Jan;89(1):233-249. doi: 10.1002/mrm.29448. Epub 2022 Sep 21.
7
MRI as a biomarker for breast cancer diagnosis and prognosis.磁共振成像作为乳腺癌诊断和预后的生物标志物
BJR Open. 2022 May 26;4(1):20220002. doi: 10.1259/bjro.20220002. eCollection 2022.
8
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.基于人工智能的决策支持可提高神经肿瘤学中肿瘤反应评估的可重复性:一项国际多读者研究。
Neuro Oncol. 2023 Mar 14;25(3):533-543. doi: 10.1093/neuonc/noac189.
9
Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients.基于学习的酰胺质子转移加权磁共振成像分析,以识别胶质瘤患者的真正进展。
Neuroimage Clin. 2022;35:103121. doi: 10.1016/j.nicl.2022.103121. Epub 2022 Jul 18.
10
MR-double-zero - Proof-of-concept for a framework to autonomously discover MRI contrasts.MR-double-zero - 用于自主发现 MRI 对比的框架的概念验证。
J Magn Reson. 2022 Aug;341:107237. doi: 10.1016/j.jmr.2022.107237. Epub 2022 May 16.